To investigate the effect of IL-31 on fibrosis in vivo, we subcutaneously injected BLM-SSc mice and PBS-treated control mice with recombinant mouse IL-31 (rmIL-31; Fig. 5a). Here, IL31 is linked to systemic sclerosis.